“CSL has an outstanding track record over the long term,” said David Grace of the Australian Foundation Investment Company, which owns about A$629 million of the company’s shares and has been invested ...

The oral solution offers precise dosing, benefiting patients with swallowing difficulties or requiring tailored dosing.

Bempedoic acid has a novel mechanism of action that inhibits a cholesterol synthesis pathway by acting on ATP (adenosine triphosphate) citrate lyase, a citrate-degrading enzyme in the liver. Bempedoic ...

Efforts to develop a gene therapy for Diamond-Blackfan anemia (DBA) — a rare, life-threatening disorder in which bone marrow ...

Treatment involves addressing the underlying deficiency through dietary changes, supplementation, or medical interventions, aiming to restore normal red blood cell production and alleviate symptoms of ...

While anemia impacts nearly a quarter of the world's population ... specifically when factoring in the under-detected ...

The global anemia treatment market is on a steady growth path, with sales expected to exceed USD 10.0 billion in 2022.